Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models

To assess the therapeutic outcome of selective block of VEGFR1, we have evaluated the activity of a new specific antagonist of VEGFR1, named iVR1 (inhibitor of VEGFR1), in syngenic and xenograft colorectal cancer models, in an artificial model of metastatization, and in laser-induced choroid neovasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicatiello, Valeria, Apicella, Ivana, Tudisco, Laura, Tarallo, Valeria, Formisano, Luigi, Sandomenico, Annamaria, Kim, Younghee, Bastos-Carvalho, Ana, Orlandi, Augusto, Ambati, Jayakrishna, Ruvo, Menotti, Bianco, Roberto, De Falco, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496375/
https://www.ncbi.nlm.nih.gov/pubmed/25868854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496375/
https://www.ncbi.nlm.nih.gov/pubmed/25868854

Ejemplares similares